Portal de investigación
Macrófagos asociados al tumor, angiogénesis tumoral y resistencia a las terapias en Cáncer Gástrico Difuso fenotipo Mesenquimal.
Datos básicos
- Protocolo:
- PI18/01508
- EUDRACT:
- NA
- NCT:
- Centro:
- HOSPITAL CLINICO UNIVERSITARIO DE VALENCIA
- Año de incio:
- 2019
- Año de finalización:
- 2021
Documentos
- No hay documentos
Grupos y Plataformas de I+D+i
Financiadores - Promotores
Resultados del Ensayo Clínico
"Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction"
Papaccio, Federica; (...); Castillo, Josefa
Article. 10.1186/s13046-022-02591-z. 2023
In the literature: December 2021.
Montagut C; (...); Cervantes A
News Item. 10.1016/j.esmoop.2021.100352. 2022
Integrative immune transcriptomic classification could improve patient selection for precision immunotherapy in advanced gastroesophageal adenocarcinoma
Segura, MC; (...); Fleitas, TC
Meeting Abstract. 10.1016/j.annonc.2022.09.065. 2022
Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study.
Gambardella, Valentina; (...); Roda, Desamparados
Article. 10.1038/s41416-021-01502-x. 2021
NRF2 through RPS6 Activation Is Related to Anti-HER2 Drug Resistance in HER2 -Amplified Gastric Cancer.
Gambardella, V; (...); Cervantes, A
Article. 10.1158/1078-0432.CCR-18-2421. 2019
Reply to the letter to the editor: adjuvant nivolumab for the management of the pathological residual disease in esophageal or junctional tumors: a word of caution by PK Garg, R. Kumar and P. Dixit
Smyth, E C; (...); Fleitas, T
Letter. 10.1016/j.annonc.2021.05.795. 2021
Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer
Tarazona, N; (...); Cervantes, A
Article. 10.1093/annonc/mdz390. 2019
The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target.
Gambardella, V; (...); Fleitas, T
Article. 10.1016/j.ctrv.2020.102015. 2020
Towards precision oncology for anti-HER2 blockade in gastroesophageal adenocarcinoma.
Gambardella, V; (...); Cervantes, A
Review. 10.1093/annonc/mdz143. 2019
Understanding mechanisms of primary resistance to checkpoint inhibitors will lead to precision immunotherapy of advanced gastric cancer
Gambardella, V, Fleitas, T, Cervantes, A
Editorial Material. 10.1093/annonc/mdz008. 2019
